Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Phase III
Biotech
CEPI to fund Moderna's pandemic flu trial after HHS walked away
With support from the U.S. government evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA bird flu vaccine forward.
Fraiser Kansteiner
Dec 18, 2025 9:40am
Vistagen's social anxiety disorder asset stumbles in phase 3
Dec 17, 2025 2:44pm
KalVista's persistence with sebetralstat pays off in ph. 3 win
Feb 13, 2024 6:30am
Merck KGaA tacks on Abbisko’s joint tumor med for $70M upfront
Dec 4, 2023 10:26am
Deciphera's tumor-tackling oral med achieves 40% response rate
Oct 30, 2023 11:00am
Relmada's depression med bounces back in open-label trial
Sep 20, 2023 11:00am
